O	O	O	0	10	Signalling	Signalling	B-NP	NN	O	0	ROOT	O
O	O	O	11	14	via	via	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	15	19	CD28	CD28	B-NP	NN	B-protein	2	PMOD	B-protein
O	O	O	20	22	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	23	28	human	human	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	29	34	naive	naive	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	35	43	neonatal	neonatal	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	44	45	T	T	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	46	57	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	O	57	58	.	.	O	.	O	1	P	O

O	O	O	60	69	Accessory	Accessory	B-NP	JJ	B-protein	2	NMOD	B-protein
O	O	O	70	79	molecules	molecule	I-NP	NNS	I-protein	3	SUB	I-protein
O	O	O	80	84	play	play	B-VP	VBP	O	0	ROOT	O
O	O	O	85	86	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	87	94	crucial	crucial	I-NP	JJ	O	6	NMOD	O
O	O	O	95	99	role	role	I-NP	NN	O	3	OBJ	O
O	O	O	100	102	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	103	106	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	107	118	development	development	I-NP	NN	O	7	PMOD	O
O	O	O	119	121	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	122	125	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	126	127	T	T	I-NP	NN	O	14	NMOD	O
O	O	O	128	132	cell	cell	I-NP	NN	O	14	NMOD	O
O	O	O	133	141	response	response	I-NP	NN	O	10	PMOD	O
O	O	O	142	144	to	to	B-PP	TO	O	14	NMOD	O
O	O	O	145	154	antigenic	antigenic	B-NP	JJ	O	17	NMOD	O
O	O	O	155	164	challenge	challenge	I-NP	NN	O	15	PMOD	O
O	O	O	164	165	.	.	O	.	O	3	P	O

O	O	O	166	168	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	169	173	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	174	182	examined	examine	I-VP	VBN	O	2	VC	O
O	O	O	183	186	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	187	191	role	role	I-NP	NN	O	3	OBJ	O
O	O	O	192	194	of	of	B-PP	IN	O	5	NMOD	O
T2	B-Protein	B-Protein	195	199	CD28	CD28	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	O	200	202	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	203	213	modulating	modulate	B-VP	VBG	O	8	PMOD	O
O	O	O	214	217	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	218	219	'	'	I-NP	``	O	14	AMOD	O
O	O	O	219	224	naive	naive	I-NP	JJ	O	14	AMOD	O
O	O	O	224	225	'	'	I-NP	''	O	14	AMOD	O
O	O	O	226	234	neonatal	neonatal	I-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	O	235	236	T	T	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	O	237	241	cell	cell	I-NP	NN	I-cell_type	17	NMOD	I-cell_type
O	O	O	242	250	response	response	I-NP	NN	O	9	OBJ	O
O	O	O	251	253	to	to	B-PP	TO	O	17	NMOD	O
O	O	O	254	258	anti	anti	B-NP	AFX	O	24	NMOD	O
O	O	O	258	259	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	O	259	262	CD2	CD2	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	262	263	-	-	O	HYPH	O	24	NMOD	O
O	O	O	263	271	mediated	mediate	B-NP	VBN	O	24	NMOD	O
O	O	O	272	282	activation	activation	I-NP	NN	O	18	PMOD	O
O	O	O	282	283	.	.	O	.	O	2	P	O

O	O	O	284	286	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	287	294	compare	compare	I-VP	VB	O	0	ROOT	O
O	O	O	295	298	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	299	303	role	role	I-NP	NN	O	2	OBJ	O
O	O	O	304	306	of	of	B-PP	IN	O	4	NMOD	O
T3	B-Protein	B-Protein	307	311	CD28	CD28	B-NP	NN	B-protein	10	AMOD	B-protein
O	O	O	311	312	,	,	O	,	O	10	P	O
O	O	O	313	321	neonatal	neonatal	B-NP	JJ	B-cell_type	10	AMOD	B-cell_type
O	O	O	322	325	and	and	I-NP	CC	I-cell_type	10	AMOD	I-cell_type
O	O	O	326	331	adult	adult	I-NP	JJ	I-cell_type	12	NMOD	I-cell_type
O	O	O	332	333	T	T	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	O	334	339	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	O	340	344	were	be	B-VP	VBD	O	2	VMOD	O
O	O	O	345	355	stimulated	stimulate	I-VP	VBN	O	13	VC	O
O	O	O	356	360	with	with	B-PP	IN	O	14	VMOD	O
O	O	O	361	362	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	363	367	pair	pair	I-NP	NN	O	15	PMOD	O
O	O	O	368	370	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	371	380	mitogenic	mitogenic	B-NP	JJ	O	23	NMOD	O
O	O	O	381	385	anti	anti	I-NP	AFX	O	23	NMOD	O
O	O	O	385	386	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	O	386	389	CD2	CD2	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	390	400	antibodies	antibody	I-NP	NNS	I-protein	18	PMOD	I-protein
O	O	O	401	403	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	404	407	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	408	416	presence	presence	I-NP	NN	O	28	NMOD	O
O	O	O	417	419	or	or	I-NP	CC	O	28	NMOD	O
O	O	O	420	427	absence	absence	I-NP	NN	O	24	PMOD	O
O	O	O	428	430	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	431	435	anti	anti	B-NP	AFX	O	33	NMOD	O
O	O	O	435	436	-	-	I-NP	HYPH	B-protein	33	NMOD	B-protein
T4	B-Protein	B-Protein	436	440	CD28	CD28	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	O	441	445	MoAb	MoAb	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	O	445	446	.	.	O	.	O	2	P	O

O	O	O	447	451	With	With	B-PP	IN	O	10	VMOD	O
O	O	O	452	456	anti	anti	B-NP	AFX	O	4	NMOD	O
O	O	O	456	457	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	O	457	460	CD2	CD2	I-NP	NN	B-protein	1	PMOD	B-protein
O	O	O	461	466	alone	alone	B-ADVP	RB	O	4	NMOD	O
O	O	O	466	467	,	,	O	,	O	10	P	O
O	O	O	468	476	neonatal	neonatal	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	477	478	T	T	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	479	484	cells	cell	I-NP	NNS	I-cell_type	10	SUB	I-cell_type
O	O	O	485	497	proliferated	proliferate	B-VP	VBD	O	0	ROOT	O
O	O	O	498	506	slightly	slightly	B-ADVP	RB	O	10	VMOD	O
O	O	O	507	510	but	but	O	CC	O	10	VMOD	O
O	O	O	511	519	produced	produce	B-VP	VBD	O	10	VMOD	O
O	O	O	520	522	no	no	B-NP	DT	O	13	OBJ	O
O	O	O	523	533	detectable	detectable	I-NP	JJ	O	14	NMOD	O
T5	B-Protein	B-Protein	534	536	IL	IL	I-NP	NN	B-protein	17	NMOD	B-protein
T5	I-Protein	I-Protein	536	537	-	-	O	HYPH	I-protein	15	P	I-protein
T5	I-Protein	I-Protein	537	538	2	2	B-NP	CD	I-protein	15	NMOD	I-protein
O	O	O	538	539	,	,	O	,	O	10	P	O
O	O	O	540	547	whereas	whereas	O	IN	O	10	VMOD	O
O	O	O	548	553	adult	adult	B-NP	JJ	B-cell_type	23	NMOD	B-cell_type
O	O	O	554	555	T	T	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	O	556	561	cells	cell	I-NP	NNS	I-cell_type	24	SUB	I-cell_type
O	O	O	562	574	proliferated	proliferate	B-VP	VBD	O	20	SBAR	O
O	O	O	575	585	vigorously	vigorously	B-ADVP	RB	O	24	VMOD	O
O	O	O	585	586	,	,	O	,	O	24	P	O
O	O	O	587	591	with	with	B-PP	IN	O	24	VMOD	O
O	O	O	592	603	significant	significant	B-NP	JJ	O	32	NMOD	O
T6	B-Protein	B-Protein	604	606	IL	IL	I-NP	NN	B-protein	32	NMOD	B-protein
T6	I-Protein	I-Protein	606	607	-	-	O	HYPH	I-protein	32	NMOD	I-protein
T6	I-Protein	I-Protein	607	608	2	2	B-NP	CD	I-protein	32	NMOD	I-protein
O	O	O	609	619	production	production	I-NP	NN	O	27	PMOD	O
O	O	O	619	620	.	.	O	.	O	10	P	O

O	O	O	621	634	Costimulation	Costimulation	B-NP	NN	O	8	SUB	O
O	O	O	635	639	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	640	644	anti	anti	B-NP	AFX	O	6	NMOD	O
O	O	O	644	645	-	-	I-NP	HYPH	B-protein	6	NMOD	B-protein
T7	B-Protein	B-Protein	645	649	CD28	CD28	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	650	654	MoAb	MoAb	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	655	662	greatly	greatly	B-VP	RB	O	8	VMOD	O
O	O	O	663	671	enhanced	enhance	I-VP	VBD	O	0	ROOT	O
O	O	O	672	675	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	676	689	proliferative	proliferative	I-NP	JJ	O	11	NMOD	O
O	O	O	690	698	response	response	I-NP	NN	O	8	OBJ	O
O	O	O	699	701	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	702	710	neonatal	neonatal	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	O	711	712	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	713	718	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	719	721	to	to	B-PP	TO	O	8	VMOD	O
O	O	O	722	728	levels	level	B-NP	NNS	O	16	PMOD	O
O	O	O	729	739	equivalent	equivalent	B-ADJP	JJ	O	17	NMOD	O
O	O	O	740	742	to	to	B-PP	TO	O	18	AMOD	O
O	O	O	743	748	those	those	B-NP	DT	O	19	PMOD	O
O	O	O	749	751	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	752	757	adult	adult	B-NP	JJ	B-cell_type	24	NMOD	B-cell_type
O	O	O	758	759	T	T	I-NP	NN	I-cell_type	24	NMOD	I-cell_type
O	O	O	760	765	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	O	765	766	,	,	O	,	O	8	P	O
O	O	O	767	774	whereas	whereas	O	IN	O	8	VMOD	O
O	O	O	775	780	adult	adult	B-NP	JJ	B-cell_type	29	NMOD	B-cell_type
O	O	O	781	782	T	T	I-NP	NN	I-cell_type	29	NMOD	I-cell_type
O	O	O	783	788	cells	cell	I-NP	NNS	I-cell_type	30	SUB	I-cell_type
O	O	O	789	795	showed	show	B-VP	VBD	O	26	SBAR	O
O	O	O	796	800	only	only	B-NP	RB	O	32	AMOD	O
O	O	O	801	807	slight	slight	I-NP	JJ	O	33	NMOD	O
O	O	O	808	817	increases	increase	I-NP	NNS	O	30	OBJ	O
O	O	O	817	818	.	.	O	.	O	8	P	O

O	O	O	819	827	Although	Although	B-SBAR	IN	O	24	VMOD	O
T8	B-Protein	B-Protein	828	830	IL	IL	B-NP	NN	B-protein	5	NMOD	B-protein
T8	I-Protein	I-Protein	830	831	-	-	O	HYPH	I-protein	2	NMOD	I-protein
T8	I-Protein	I-Protein	831	832	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	833	842	secretion	secretion	I-NP	NN	O	6	SUB	O
O	O	O	843	846	was	be	B-VP	VBD	O	1	SBAR	O
O	O	O	847	856	increased	increase	I-VP	VBN	O	6	VC	O
O	O	O	857	859	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	860	863	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	864	872	presence	presence	I-NP	NN	O	8	PMOD	O
O	O	O	873	875	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	876	880	anti	anti	B-NP	AFX	O	15	NMOD	O
O	O	O	880	881	-	-	I-NP	HYPH	B-protein	15	NMOD	B-protein
T9	B-Protein	B-Protein	881	885	CD28	CD28	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	886	890	MoAb	MoAb	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	890	891	,	,	O	,	O	24	P	O
O	O	O	892	900	neonatal	neonatal	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	O	901	902	T	T	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	O	903	907	cell	cell	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
T10	B-Protein	B-Protein	908	910	IL	IL	I-NP	NN	B-protein	23	NMOD	B-protein
T10	I-Protein	I-Protein	910	911	-	-	O	HYPH	I-protein	23	NMOD	I-protein
T10	I-Protein	I-Protein	911	912	2	2	B-NP	CD	I-protein	23	NMOD	I-protein
O	O	O	913	923	production	production	I-NP	NN	O	24	SUB	O
O	O	O	924	932	remained	remain	B-VP	VBD	O	0	ROOT	O
O	O	O	933	938	lower	low	B-ADJP	JJR	O	24	PRD	O
O	O	O	939	943	than	than	B-PP	IN	O	25	AMOD	O
O	O	O	944	946	in	in	B-PP	IN	O	26	PMOD	O
O	O	O	947	953	adults	adult	B-NP	NNS	O	27	PMOD	O
O	O	O	953	954	.	.	O	.	O	24	P	O

O	O	O	955	957	In	In	B-PP	IN	O	13	VMOD	O
O	O	O	958	966	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	966	967	,	,	O	,	O	13	P	O
O	O	O	968	979	enhancement	enhancement	B-NP	NN	O	13	SUB	O
O	O	O	980	982	of	of	B-PP	IN	O	4	NMOD	O
T11	B-Protein	B-Protein	983	985	IL	IL	B-NP	NN	B-RNA	9	NMOD	B-RNA
T11	I-Protein	I-Protein	985	986	-	-	B-NP	HYPH	I-RNA	9	NMOD	I-RNA
T11	I-Protein	I-Protein	986	987	2	2	I-NP	CD	I-RNA	9	NMOD	I-RNA
O	O	O	988	992	mRNA	mRNA	I-NP	NN	I-RNA	10	NMOD	I-RNA
O	O	O	993	1003	expression	expression	I-NP	NN	O	5	PMOD	O
O	O	O	1004	1006	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	1007	1015	neonates	neonate	B-NP	NNS	O	11	PMOD	O
O	O	O	1016	1019	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1020	1027	similar	similar	B-ADJP	JJ	O	13	PRD	O
O	O	O	1028	1030	to	to	B-PP	TO	O	14	AMOD	O
O	O	O	1031	1036	adult	adult	B-NP	JJ	O	17	NMOD	O
O	O	O	1037	1043	levels	level	I-NP	NNS	O	15	PMOD	O
O	O	O	1043	1044	.	.	O	.	O	13	P	O

O	O	O	1045	1049	Anti	Anti	B-NP	AFX	O	5	NMOD	O
O	O	O	1049	1050	-	-	I-NP	HYPH	B-protein	4	NMOD	B-protein
T12	B-Protein	B-Protein	1050	1054	CD28	CD28	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	O	1055	1059	MoAb	MoAb	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	O	1060	1073	costimulation	costimulation	I-NP	NN	O	6	SUB	O
O	O	O	1074	1083	increased	increase	B-VP	VBD	O	0	ROOT	O
T17	B-Entity	B-Entity	1084	1086	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T17	I-Entity	I-Entity	1087	1092	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T17	I-Entity	I-Entity	1093	1094	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	O	1095	1101	levels	level	I-NP	NNS	O	6	OBJ	O
O	O	O	1102	1104	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	1105	1113	neonates	neonate	B-NP	NNS	O	11	PMOD	O
O	O	O	1113	1114	,	,	O	,	O	6	P	O
O	O	O	1115	1121	albeit	albeit	B-PP	IN	O	6	VMOD	O
O	O	O	1122	1124	to	to	B-PP	TO	O	14	PMOD	O
O	O	O	1125	1131	levels	level	B-NP	NNS	O	15	PMOD	O
O	O	O	1132	1137	lower	low	B-ADJP	JJR	O	16	NMOD	O
O	O	O	1138	1142	than	than	B-PP	IN	O	17	AMOD	O
O	O	O	1143	1147	that	that	B-NP	DT	O	18	PMOD	O
O	O	O	1148	1150	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1151	1157	adults	adult	B-NP	NNS	O	20	PMOD	O
O	O	O	1157	1158	.	.	O	.	O	6	P	O

O	O	O	1159	1162	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1163	1171	cellular	cellular	I-NP	JJ	O	3	NMOD	O
O	O	O	1172	1181	mechanism	mechanism	I-NP	NN	O	17	SUB	O
O	O	O	1182	1191	governing	govern	B-VP	VBG	O	3	NMOD	O
O	O	O	1192	1195	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1196	1206	diminished	diminish	I-NP	VBN	O	8	NMOD	O
O	O	O	1207	1220	proliferative	proliferative	I-NP	JJ	O	8	NMOD	O
O	O	O	1221	1229	response	response	I-NP	NN	O	4	OBJ	O
O	O	O	1230	1232	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1233	1241	neonatal	neonatal	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	O	1242	1243	T	T	I-NP	NN	I-cell_type	12	NMOD	I-cell_type
O	O	O	1244	1255	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	1256	1258	to	to	B-PP	TO	O	8	NMOD	O
O	O	O	1259	1263	anti	anti	B-NP	AFX	O	16	NMOD	O
O	O	O	1263	1264	-	-	I-NP	HYPH	O	16	NMOD	O
O	O	O	1264	1267	CD2	CD2	I-NP	NN	B-protein	13	PMOD	B-protein
O	O	O	1268	1271	may	may	B-VP	MD	O	28	VMOD	O
O	O	O	1272	1281	therefore	therefore	I-VP	RB	O	17	VMOD	O
O	O	O	1282	1284	be	be	I-VP	VB	O	28	VMOD	O
O	O	O	1285	1288	due	due	B-PP	JJ	O	28	VMOD	O
O	O	O	1289	1291	to	to	B-PP	TO	O	20	AMOD	O
O	O	O	1292	1301	decreased	decrease	B-NP	VBN	O	26	NMOD	O
T18	B-Entity	B-Entity	1302	1304	NF	NF	I-NP	NN	B-protein	25	NMOD	B-protein
T18	I-Entity	I-Entity	1305	1310	kappa	kappa	I-NP	NN	I-protein	25	NMOD	I-protein
T18	I-Entity	I-Entity	1311	1312	B	B	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	1313	1322	induction	induction	I-NP	NN	O	21	PMOD	O
O	O	O	1322	1323	,	,	O	,	O	28	P	O
O	O	O	1324	1331	reduced	reduce	B-VP	VBD	O	0	ROOT	O
T13	B-Protein	B-Protein	1332	1334	IL	IL	B-NP	NN	B-RNA	32	NMOD	B-RNA
T13	I-Protein	I-Protein	1334	1335	-	-	B-NP	HYPH	I-RNA	29	NMOD	I-RNA
T13	I-Protein	I-Protein	1335	1336	2	2	I-NP	CD	I-RNA	32	NMOD	I-RNA
O	O	O	1337	1341	mRNA	mRNA	I-NP	NN	I-RNA	33	NMOD	I-RNA
O	O	O	1342	1352	expression	expression	I-NP	NN	O	39	NMOD	O
O	O	O	1353	1356	and	and	O	CC	O	39	NMOD	O
O	O	O	1357	1366	deficient	deficient	B-NP	JJ	O	39	NMOD	O
T14	B-Protein	B-Protein	1367	1369	IL	IL	I-NP	NN	B-protein	39	NMOD	B-protein
T14	I-Protein	I-Protein	1369	1370	-	-	O	HYPH	I-protein	39	NMOD	I-protein
T14	I-Protein	I-Protein	1370	1371	2	2	B-NP	CD	I-protein	39	NMOD	I-protein
O	O	O	1372	1382	production	production	I-NP	NN	O	28	OBJ	O
O	O	O	1382	1383	.	.	O	.	O	28	P	O

O	O	O	1384	1392	Although	Although	B-SBAR	IN	O	22	VMOD	O
O	O	O	1393	1397	anti	anti	B-NP	AFX	O	6	NMOD	O
O	O	O	1397	1398	-	-	I-NP	HYPH	B-protein	5	NMOD	B-protein
T15	B-Protein	B-Protein	1398	1402	CD28	CD28	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	O	1403	1407	MoAb	MoAb	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	1408	1421	costimulation	costimulation	I-NP	NN	O	7	SUB	O
O	O	O	1422	1430	enhances	enhance	B-VP	VBZ	O	1	SBAR	O
O	O	O	1431	1434	all	all	B-NP	DT	O	7	OBJ	O
O	O	O	1435	1437	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1438	1441	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1442	1447	above	above	I-NP	JJ	O	12	NMOD	O
O	O	O	1448	1455	signals	signal	I-NP	NNS	O	9	PMOD	O
O	O	O	1455	1456	,	,	O	,	O	22	P	O
T19	B-Entity	B-Entity	1457	1459	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T19	I-Entity	I-Entity	1460	1465	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T19	I-Entity	I-Entity	1466	1467	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1468	1471	and	and	O	CC	O	21	NMOD	O
T16	B-Protein	B-Protein	1472	1474	IL	IL	B-NP	NN	B-protein	21	NMOD	B-protein
T16	I-Protein	I-Protein	1474	1475	-	-	O	HYPH	I-protein	18	NMOD	I-protein
T16	I-Protein	I-Protein	1475	1476	2	2	B-NP	CD	I-protein	18	NMOD	I-protein
O	O	O	1477	1483	levels	level	I-NP	NNS	O	22	SUB	O
O	O	O	1484	1490	remain	remain	B-VP	VBP	O	0	ROOT	O
O	O	O	1491	1496	lower	low	B-ADJP	JJR	O	22	PRD	O
O	O	O	1497	1501	than	than	B-PP	IN	O	23	AMOD	O
O	O	O	1502	1504	in	in	B-PP	IN	O	24	PMOD	O
O	O	O	1505	1511	adults	adult	B-NP	NNS	O	25	PMOD	O
O	O	O	1511	1512	,	,	O	,	O	22	P	O
O	O	O	1513	1523	suggesting	suggest	B-VP	VBG	O	22	VMOD	O
O	O	O	1524	1527	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	1528	1532	need	need	I-NP	NN	O	28	OBJ	O
O	O	O	1533	1536	for	for	B-PP	IN	O	30	NMOD	O
O	O	O	1537	1544	further	further	B-NP	JJ	O	34	NMOD	O
O	O	O	1545	1555	activation	activation	I-NP	NN	O	34	NMOD	O
O	O	O	1556	1568	requirements	requirement	I-NP	NNS	O	31	PMOD	O
O	O	O	1569	1571	in	in	B-PP	IN	O	34	NMOD	O
O	O	O	1572	1575	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	1576	1583	neonate	neonate	I-NP	NN	O	35	PMOD	O
O	O	O	1583	1584	.	.	O	.	O	22	P	O
